SEC Charges Company and Two Executives for Misleading COVID-19 Disclosures
- Written by Newsfile
Washington, D.C.--(Newsfile Corp. - July 7, 2021) - The Securities and Exchange Commission today announced charges against Parallax Health Sciences Inc. for making misleading statements about its efforts to fight COVID-19. The SEC also charged Parallax’s Chief Executive Officer Paul Arena and its Chief Technology Officer...